Russell Wyborski

Russell Wyborski is a Director at the Crohn's & Colitis Foundation and an accomplished professional in the field of medical research and innovation. He has over 35 years of experience in drug development and discovery6, which makes him a valuable asset to the foundation and the broader medical community.

Professional Background

Dr. Wyborski is described as an outstanding scientist and team player with diverse technical expertise.1 His work primarily focuses on inflammatory bowel disease (IBD) and microbiome research.

Role at Crohn's & Colitis Foundation

As a Director at the Crohn's & Colitis Foundation, Dr. Wyborski is involved in several key initiatives:

1. Research Team Leadership: He works with a talented research team to shepherd innovative and critical projects related to Crohn's disease and ulcerative colitis.2

2. IBD Ventures Program: Dr. Wyborski is part of the team leading the IBD Ventures program, which invests in companies developing promising treatments for IBD.7

3. Innovation Promotion: He is involved in organizing and participating in events that drive innovation in IBD treatment, such as the IBD Innovate Pitch Competition.5

Speaking Engagements and Conferences

Dr. Wyborski is a frequent speaker and attendee at industry conferences, particularly those focused on microbiome research:

• He spoke at Microbiome Connect: USA 2023 in Boston.3
• He plans to attend the 2024 Microbiome Connect USA conference.4

These engagements demonstrate his commitment to staying at the forefront of microbiome research and its applications in treating IBD.

Dr. Wyborski's LinkedIn profile showcases his passion for advancing medical research and improving the lives of those affected by Crohn's disease and ulcerative colitis. His work at the Crohn's & Colitis Foundation involves not only scientific research but also supporting innovative companies and raising awareness about IBD-related issues, such as the benefits of ostomies for some patients.8